PanCareLIFE researchers at the University of Bern have just published a new paper ‘Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study’, funded in part by PanCareLIFE. You can read the full, open access article here.
Our Danish colleagues from KB are co-authors on the publication ‘Gastrointestinal and liver disease in Adult Life After Childhood Cancer in Scandinavia: A population-based cohort study’ in the International Journal of Cancer.
Our publication ‘Fertility preservation in children, adolescents, and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations’ has been published in Cancer (2016 Jul 15;122(14):2216-23. doi: 10.1002/cncr.30047.).
You can read the full, open access article here.
The Danish Cancer Society Research Center, project partner in PanCareLIFE, have recently published the first large-scale study of the lifetime risk for autoimmune diseases after childhood cancer, with risk estimates for a broad range of well-defined, medically verified autoimmune diseases. in Annals of the Rheumatic Diseases (Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS) – Ann Rheum Dis. 2015 Nov 10. pii: annrheumdis-2015-207659).
You can read the press release here.
The first author Anna S. Holmqvist, MD, PhD from Lund in Sweden has also been interviewed for a news story in The Lancet Oncology.
See our Publications page for other PanCareLIFE related publications.
PanCareLIFE Coordinator Dr. Peter Kaatsch commented:
There is no place for competition in paediatric oncology. We all work in a team. The PanCare network summarises this spirit: cooperation.
Dr. Gabriele Calaminus, leader of the health-related quality of life research in PanCareLIFE, noted:
The increase in the childhood cancer cure rate has been dramatic over the past twenty years. We now have more children who survive than who die. But what happens to them when they walk out the doors of the ‘Kinderonko’, when they’re finished with their treatments? The price of their recovery remains very high.
Through research into the late effects of cancer treatment PanCareLIFE aims to ensure that survivors of cancer diagnosed before age 25 enjoy the same quality of life and opportunities as their peers who have not had cancer.
Read more about PanCareLIFE, PanCare and PanCareSurFup in the recent newsletter from the Boyne Research Institute.
The PanCare network has been described in a paper published in the European Journal of Cancer. The PanCareLIFE project is presented alongside our sister project, PanCareSurFup. Both projects have arisen from work of the PanCare network and its collaborators.
A new publication from PanCareLIFE and PanCareSurFup partners about ‘Childhood cancer survivor cohorts in Europe’ has been published in Acta Oncologica.
The paper presents an overview of the current large, national and pan-European studies of late effects after childhood cancer, in particular the EU-funded collaborative research projects PanCareSurFup and PanCareLIFE. The large cohort studies described in the paper aim to provide every European childhood cancer survivor with better care and better long-term health so that they reach their full potential and enjoy the same quality of life and opportunities as their peers, as much as is possible.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602030. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.